Dr Jack Leslie
Erik Ramon Gil
Kathryn Gilroy
Dr Saimir Luli
Maja Laszczewska
et al. | CXCR2 inhibition enables NASH-HCC immunotherapy | 2022 |
|
Dr Catherine Willoughby
Professor Helen Reeves
Professor Arun Sanyal
| Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis | 2021 |
|
Dr Catherine Willoughby
Huw Thomas
Dr Elaine Willmore
Suzanne Kyle
Dr Anita Wittner
et al. | Selective DNA-PKcs Inhibition Extends the Therapeutic Index of Localized Radiotherapy and Chemotherapy | 2019 |
|
Dr Jane Margetts
Laura Ogle
Dr Anthony Chan
Dr David Jamieson
Dr Catherine Willoughby
et al. | Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma? | 2018 |
|
Dr Catherine Willoughby
Professor Helen Reeves
| Combination PARP and HDAC inhibition as a therapeutic strategy targeting liver cancer stem cells? | 2016 |
|
Laura Ogle
Dr James Orr
Dr Catherine Willoughby
Dr Claire Hutton
Professor Stuart McPherson
et al. | Imagestream detection and characterisation of circulating tumour cells - a liquid biopsy for hepatocellular carcinoma? | 2016 |
|
Liam Cornell
Dr Joanne Martin
Laura Ogle
Dr Catherine Willoughby
Dr Despina Televantou
et al. | DNA-PK-A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival | 2015 |
|
